AIMM Therapeutics BV

Esther Merk
AIMM Therapeutics BV

Telefoon 0205662145 | E-mail emerk@aimmtherapeutics.com

Bezig met laden

Vergelijkbare vacatures

Senior Scientist/Associate director (PhD) Down Stream Processing

We have an opportunity for a highly motivated and talented Senior Scientist/Associate Director to support our antibody Discovery Research and Development programs. Specifically, we are recruiting for a senior scientist/associate director to lead & build our antibody Down Stream Processing (DSP) group. The successful candidate will be responsible for in house DSP development and external DSP activities, including antibody analytics. The candidate will identify areas to expand our internal capabilities in these areas. She/he will supervise the in-house DSP team (2-3 FTE). In addition, she/he will support management of outsourced (GMP) DSP activities. Writing & review of IMPD/IND enabling documentation will also be part of the job.

The appointment with AIMM Therapeutics BV will be a full-time function (40 h/week), initially for 12 months. Salary is competitive with position and experience.

 

Vaardigheden

Requirements: 

PhD in life sciences (Biotechnology or related) and ≥5 years of experience in the pharmaceutical industry in the area of DSP development and manufacturing of biologics, most preferable antibodies. Experience with managing outsourced CMO activities as well as relevant guidelines is a must. A proven track record in writing development protocols and reports, and documents for IND/IMPD filing is a pre. Strong communication & project management skills are essential. Teamwork is at the heart of our success and we expect the candidate to be able to thrive in that environment where we have a can-do mentality and regularly go above-and-beyond.

Over de werkgever

AIMM Therapeutics BV is a privately-owned biotech company that develops human monoclonal antibodies for the treatment of Cancer. AIMM Therapeutics’ uses its proprietary platform technology for the efficient selection, characterisation and affinity maturation of antibodies. Currently we are advancing several unique and exciting antibodies programs through discovery Research and preclinical Development. As a result, we are growing our organisation to support our expansion in both Research and Development.

Uren per week: 40

Contract: vast

Solliciteer later
Contactgegevens

Esther Merk
0205662145
emerk@aimmtherapeutics.com

AIMM Therapeutics BV
Meibergdreef 59
1105BA,  Amsterdam Zuidoost